Mendota Financial Group, LLC Catalyst Pharmaceuticals, Inc. Transaction History
Mendota Financial Group, LLC
- $209 Billion
- Q3 2024
A detailed history of Mendota Financial Group, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Mendota Financial Group, LLC holds 12 shares of CPRX stock, worth $258. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12Holding current value
$258% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CPRX
# of Institutions
295Shares Held
97.3MCall Options Held
29.2KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$403 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$197 Million2.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$175 Million0.0% of portfolio
-
State Street Corp Boston, MA6.03MShares$130 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3MShares$64.7 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.22B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...